South Plains Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.2K Buy
296
+25
+9% +$3.83K 0.03% 172
2025
Q4
$37.4K Hold
271
0.02% 192
2025
Q3
$34.8K Buy
271
+76
+39% +$9.27K 0.02% 174
2025
Q2
$23.6K Buy
195
+143
+275% +$16.1K 0.02% 175
2025
Q1
$5.8K Buy
+52
New +$5.54K ﹤0.01% 200

Other funds holding NVS

South Plains Financial's NVS Position: Q1 2026 in Review

South Plains Financial increased its Novartis (NVS) stake by 9.2% in Q1 2026, buying an estimated $3.83K and bringing the position to 296 shares worth $45.2K. The position accounts for 0.03% of the portfolio, ranked #172.

South Plains Financial first reported a position in NVS in Q1 2025 and has held it in 5 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • South Plains Financial held 296 shares of Novartis worth $45.2K as of Q1 2026.
  • South Plains Financial bought 25 Novartis shares in Q1 2026, an estimated $3.83K.
  • Novartis made up 0.03% of South Plains Financial's portfolio in Q1 2026, its #172 holding.
  • South Plains Financial first reported a position in Novartis in Q1 2025 and has held it in 5 quarters since.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on South Plains Financial's 13F filing for Q1 2026, filed 13 May 2026.